LIFECODES was acquired by Immucor in March of 2013 and specializes in diagnostic assays designed for the blood bank, special coagulation and transplantation labs.
We provide clinicians with reliable and innovative products serving the unique needs of today’s modern diagnostic testing labs.
PF4 Enhanced Assay (X-HAT13/X-HAT45)
An ELISA assay for the detection of antibodies reactive with PF4 which are known to be associated with Type II HIT.
The PF4 Enhanced assay contains micro wells where a complex of PF4:PVS has been immobilized.
This assay will detect antibodies of IgG, IgA and IgM isotypes.
PF4 IgG Assay (HAT13G/HAT45G)
An ELISA assay for the detection of antibodies reactive with PF4 which are known to be associated with Type II HIT, where an increased association with platelet functional testing (Serotonin Release Assay) is desired.
This kit will detect only antibodies specific to the IgG isotype.
ATS-13 Activity Assay* (ATS-13)
A fluorometric assay utilizing a synthetic segment of von Willebrand Factor as a substrate for the ADAMTS-13 enzyme.
Determination of ADAMTS-13 activity is achieved by a fluorescent resonance energy transfer (FRET) reaction where an increase in fluorescence is caused by the specific cleavage of the synthetic substrate.
*For Research Use Only.
VWF & Propeptide Assay*
An ELISA assay for the measurement of von Willebrand Factor (VWF) and von Willebrand Factor Propeptide (VWF-PP) levels in human plasma using a fluorometric endpoint.
An increased ratio of VWF-PP to VWF has been demonstrated in individual characterized as having a Type 1C (increased clearance or Vincenza) von Willebrand Disease1 or acquired thrombotic thrombocytopenic purpura.2
- Haberichter, S.L. et.al., Blood. 2008, May 15; 111(10):4979-85
- Stufano, F.. al., J. Throm Haemost. 2012; 10:728-30
*For Research Use Only, not for use in diagnostic procedures in US and Canada.
Factor VIII Antibody Screen (F8S)
An ELISA assay to detect IgG antibodies reactive with FVIII.
Antibodies against FVIII occur in individuals who receive human Factor VIII as a treatment for Hemophilia A.
The Factor VIII Antibody Screen will detect both inhibitory antibodies and non-inhibitory antibodies of the IgG isotype to Factor VIII in patient plasma or serum.